Multimodal Monitoring in Patients With Spontaneous Intracerebral Hemorrhage
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02326571|
Recruitment Status : Completed
First Posted : December 29, 2014
Last Update Posted : April 11, 2017
Spontaneous intracerebral bleeding also known as spontaneous intracerebral hemorrhage (sICH) constitute 10-15 % of all apoplexies. The Prognosis is considerably worse than it is for the larger population of patients suffering from cerebral thrombosis. Development of brain edema seemingly contributes to the disadvantageous prognosis. However, the mechanisms behind is only understood fragmentarily.
By using multimodal neuro monitoring, the investigators seek to investigate electrophysiological and metabolic processes, which seem to accompany the formation of edema and clinical deterioration in patients suffering from sICH.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||8 participants|
|Official Title:||Multimodal Monitoring in Patients With Spontaneous Intracerebral Hemorrhage|
|Study Start Date :||December 2014|
|Actual Primary Completion Date :||June 20, 2016|
|Actual Study Completion Date :||June 20, 2016|
|spontaneous intracerebral hemorrhage|
- Secondary brain injury [ Time Frame: 10 days ]Assessed by GCS, CAM-ICU, mRS, Imaging, EEG background activity.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02326571
|Copenhagen, Denmark, 2100|
|Principal Investigator:||Christian K Friberg, MD|